Factors Influencing Physicians’ Judgments of Adherence and Treatment Decisions for Patients with HIV Disease
- 1 February 2001
- journal article
- research article
- Published by SAGE Publications in Medical Decision Making
- Vol. 21 (1), 28-36
- https://doi.org/10.1177/0272989x0102100104
Abstract
New medications for HIV reduce mortality and morbidity but require strict adherence. Thus, physicians treating HIV-positive patients must weigh both disease severity and likelihood of adherence when deciding whether to start patients on treatment. A national sample of 495 physicians surveyed via mail responded to clinical scenarios depicting HIV-positive patients and indicated whether they would start patients on medication (response rate = 53%). Scenarios varied on the patient characteristics of gender, disease severity, ethnicity, and risk group. Physicians predicted that patients with less severe disease, former injection drug users, and African American men would be less likely to adhere. Perceived adherence and disease severity influenced treatment decisions. Results are discussed in the context of attitudes about minority groups and injection drug users, which may influence adherence judgments in practice settings. Psychological research to identify better methods of predicting medication adherence may serve to inform medical decision making.Keywords
This publication has 29 references indexed in Scilit:
- HIV-1 Drug Resistance in Newly Infected IndividualsJAMA, 1999
- Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV InfectionJAMA, 1999
- Protease Inhibitor Use Among a Community Sample of People With HIV DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease InhibitorsNew England Journal of Medicine, 1998
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected PatientsJAMA, 1998
- Physician concurrence with primary care guidelines for persons with HIV diseaseInternational Journal of STD & AIDS, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Transmission of Human Immunodeficiency Virus Type 1 Resistant to Nevirapine and ZidovudineThe Journal of Infectious Diseases, 1997